Filtrer par genre

Investigating HLH

Investigating HLH

Sobi Inc.

Investigating HLH, brought to you by Sobi Inc., is a podcast that takes a deep dive into the complex world of hemophagocytic lymphohistiocytosis, or HLH. As a rare and fatal disease that was once considered incurable, HLH presents with a range of severe signs and symptoms that make diagnosis difficult. Join us as we discuss insights about HLH from all angles with various experts in the field of hematology-oncology who have helped to advance the understanding and treatment of this devastating disease. When treating patients with HLH, knowledge is power—because knowing what to look for can save lives.

9 - Treating Hemophagocytic Lymphohistiocytosis (HLH)
0:00 / 0:00
1x
  • 9 - Treating Hemophagocytic Lymphohistiocytosis (HLH)

    Dr Saara Kaviany and Dr Blachy J. Dávila Saldaña discuss the overall treatment goals and management strategies for patients with hemophagocytic lymphohistiocytosis (HLH).

    Wed, 5 Jun 2024 - 35min
  • 8 - Diagnosing Hemophagocytic Lymphohistiocytosis (HLH)

    Adam Narloch speaks with Dr Ashish Kumar and Dr Scott Canna to discuss the challenges involved with diagnosing and managing hemophagocytic lymphohistiocytosis (HLH).

    Wed, 15 May 2024 - 53min
  • 7 - An Introduction to Hemophagocytic Lymphohistiocytosis (HLH)

    Adam Narloch speaks with Dr Michelle Hermiston to discuss the history of hemophagocytic lymphohistiocytosis (HLH), advances in clinical understanding, and why recognition of this rare hyperinflammatory syndrome remains important.

    Mon, 22 Apr 2024 - 23min
  • 6 - What Is Macrophage Activation Syndrome (MAS)?

    Adam Narloch speaks with Dr Randy Cron and Dr Daniella Schwartz about the pathology of macrophage activation syndrome (MAS), including its pathophysiology and relationship to hemophagocytic lymphohistiocytosis (HLH).

    Tue, 23 Sep 2025 - 29min
  • 5 - Monitoring Treatment Response

    Kari Magee speaks with Dr Bethany Verkamp to discuss her research on evaluating treatment response to etoposide-based treatment in patients with hemophagocytic lymphohistiocytosis (HLH).

    Tue, 25 Feb 2025 - 15min
Afficher plus d'épisodes